BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37991344)

  • 1. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
    Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
    Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
    Sosa Cuevas E; Valladeau-Guilemond J; Mouret S; Roubinet B; de Fraipont F; Landemarre L; Charles J; Bendriss-Vermare N; Chaperot L; Aspord C
    Front Immunol; 2022; 13():1040600. PubMed ID: 36353633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
    Sosa Cuevas E; Roubinet B; Mouret S; Thépaut M; de Fraipont F; Charles J; Fieschi F; Landemarre L; Chaperot L; Aspord C
    Front Immunol; 2023; 14():1120434. PubMed ID: 36891308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.
    Ouaguia L; Dufeu-Duchesne T; Leroy V; Decaens T; Reiser JB; Sosa Cuevas E; Durantel D; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Clin Transl Immunology; 2020; 9(12):e1208. PubMed ID: 33312564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From structure to function - Ligand recognition by myeloid C-type lectin receptors.
    Fischer S; Stegmann F; Gnanapragassam VS; Lepenies B
    Comput Struct Biotechnol J; 2022; 20():5790-5812. PubMed ID: 36382179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
    van Kooyk Y
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy.
    Niveau C; Sosa Cuevas E; Saas P; Aspord C
    Immunology; 2024 May; ():. PubMed ID: 38742251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDCA1
    Sosa Cuevas E; Ouaguia L; Mouret S; Charles J; De Fraipont F; Manches O; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Clin Transl Immunology; 2020; 9(11):e1190. PubMed ID: 33282290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
    Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Front Immunol; 2019; 10():112. PubMed ID: 30778353
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
    de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
    Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells.
    Hsu SC; Chen CH; Tsai SH; Kawasaki H; Hung CH; Chu YT; Chang HW; Zhou Y; Fu J; Plunkett B; Su SN; Vieths S; Lee RT; Lee YC; Huang SK
    J Biol Chem; 2010 Mar; 285(11):7903-10. PubMed ID: 20080962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
    Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
    Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated.
    Klaver EJ; Kuijk LM; Laan LC; Kringel H; van Vliet SJ; Bouma G; Cummings RD; Kraal G; van Die I
    Int J Parasitol; 2013 Mar; 43(3-4):191-200. PubMed ID: 23220043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells.
    Carenza C; Calcaterra F; Oriolo F; Di Vito C; Ubezio M; Della Porta MG; Mavilio D; Della Bella S
    Front Immunol; 2019; 10():1325. PubMed ID: 31244860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human blood dendritic cell subsets exhibit discriminative pattern recognition receptor profiles.
    Lundberg K; Rydnert F; Greiff L; Lindstedt M
    Immunology; 2014 Jun; 142(2):279-88. PubMed ID: 24444310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN.
    Meyer S; van Liempt E; Imberty A; van Kooyk Y; Geyer H; Geyer R; van Die I
    J Biol Chem; 2005 Nov; 280(45):37349-59. PubMed ID: 16155001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human DC-SIGN binds specific human milk glycans.
    Noll AJ; Yu Y; Lasanajak Y; Duska-McEwen G; Buck RH; Smith DF; Cummings RD
    Biochem J; 2016 May; 473(10):1343-53. PubMed ID: 26976925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation-dependent interactions of C-type lectin DC-SIGN with colorectal tumor-associated Lewis glycans impair the function and differentiation of monocyte-derived dendritic cells.
    Nonaka M; Ma BY; Murai R; Nakamura N; Baba M; Kawasaki N; Hodohara K; Asano S; Kawasaki T
    J Immunol; 2008 Mar; 180(5):3347-56. PubMed ID: 18292560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses.
    van Vliet SJ; García-Vallejo JJ; van Kooyk Y
    Immunol Cell Biol; 2008 Oct; 86(7):580-7. PubMed ID: 18679407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells.
    Front Immunol; ; . PubMed ID: 32161592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.